Template:AHA SAH BP Guidelines: Difference between revisions
No edit summary |
Ostermayer (talk | contribs) (Marked this version for translation) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>=== | <noinclude><languages/></noinclude> | ||
<translate> | |||
===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>=== <!--T:1--> | |||
<!--T:2--> | |||
#No well-controlled studies exist that answer whether BP control influences rebleeding | #No well-controlled studies exist that answer whether BP control influences rebleeding | ||
#BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[EBQ:Evidence_Levels|Level of Evidence B]]). | #BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[Special:MyLanguage/EBQ:Evidence_Levels|Level of Evidence B]]). | ||
#Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided) | #Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided) | ||
</translate> | |||
Latest revision as of 02:11, 18 January 2026
AHA Aneurysmal SAH BP Guidelines[1]
- No well-controlled studies exist that answer whether BP control influences rebleeding
- BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, Level of Evidence B).
- Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided)